How the product works:
Who it is recommended for:
Studies and clinical evidence:
Artesunate is recommended by the World Health Organization as the first-line treatment for severe malaria. Clinical trials have demonstrated lower mortality rates, faster parasite clearance and improved safety compared to quinine.
The medicine works by rapidly killing malaria parasites in the bloodstream, preventing disease progression and complications.
The product is administered intravenously or intramuscularly after reconstitution according to medical guidelines. Treatment is initiated under medical supervision and followed by oral antimalarial therapy once the patient’s condition improves.
Contraindications
Side effects:
